✨
AI Summary
- Breakdown of the US FDA's CDER leadership changes.
- Impact of Richard Pazdur's retirement and interim replacement.
- Potential effects on drug sponsors and CDER operations.
Guests on This Episode
RP
Richard Pazdur
2 podcast appearances
TH
Tracy Beth Hoeg
1 podcast appearance